Extreme Prostate‐Specific Antigen Response to Infusional 5‐Flourouracil in Castrate‐Resistant Prostate Cancer

Prostate cancer that has progressed after androgen deprivation, abiraterone, and taxane therapy is challenging to treat successfully. Herein we report a dramatic response to continuous‐infusion 5‐fluorouracil (5‐FU) at a dose of 200 mg/m(2) in a patient with rapidly progressive, heavily pretreated,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncologist
Glavni autori: Manogue, Charlotte, Ledet, Elisa, Guddati, A. Kumar, Lewis, Brian, Sartor, Oliver
Format: Artigo
Jezik:Inglês
Izdano: AlphaMed Press 2017
Teme:
Brief Communications
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905692/
https://ncbi.nlm.nih.gov/pubmed/29259071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0450
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items